XOMA Royalty Corporation

NASDAQ: XOMA
Share price (8/8/25): $26.50
Market cap (8/8/25): $317 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

Prospectuses and Registrations Filter

Info about tender offer or issuer

Info about tender offer or issuer

Third party tender offer – amended

Third party tender offer

Info about tender offer or issuer

Ownership Filter

Vanguard Group Inc

News Filter

Material Modification to Rights of Security Holders, Change in Directors, Officers or Compensation, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Reports First Quarter 2025 Financial Results and Highlights Business Achievements

Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business Achievements

Pulmokine, Inc. Financial Statements December 31, 2023 Pulmokine, Inc. Index to the Financial Statements December 31, 2023

Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC